Sunrise Partners Limited Partnership »

Zentalis Pharmaceuticals shares owned by Sunrise Partners Limited Partnership

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Sunrise Partners Limited Partnership from 13F filings

Historical chart of Sunrise Partners Limited Partnership investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Sunrise Partners Limited Partnership consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Sunrise Partners Limited Partnership

Quarter filed Position value Share count Share price at filing
2024-09-30 $37k 10k 3.68
2021-06-30 $288k 5.4k 53.28

More positions owned by Sunrise Partners Limited Partnership

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Alcoa Call Option (AA)
ConocoPhillips (COP)
Teck Resources CL B Call Option (TECK)
Intel Corporation (INTC)
Aptiv Com Shs
Wolfspeed Note 1.750% 5/0 (Principal)
Nio Note 4.625%10/1 (Principal)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Allegro Microsystems Ord (ALGM)
EQT Corporation (EQT)
Ssr Mining In Note 2.500% 4/0 (Principal)
Darling International (DAR)
Zto Express Cayman Note 1.500% 9/0 (Principal)
Draftkings Com Cl A Call Option (DKNG)

View all positions for Sunrise Partners Limited Partnership

Top funds holding Zentalis Pharmaceuticals

Matrix Capital Management Company
Eventide Asset Management
BlackRock
Vanguard Group
Citadel Advisors
Decheng Capital
Opaleye Management
Morgan Stanley
Almitas Capital
PRIMECAP Management Company
Geode Capital Management
State Street Corporation
D. E. Shaw & Co
Verition Fund Management
MPM Oncology Impact Management

View all funds holding Zentalis Pharmaceuticals